PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

ITN achieves scientific manuscript first -- provides open, interactive access to clinical trial data

2013-08-01
(Press-News.org) WA, Seattle (July 26, 2013) – In an article reporting the 18-month results of the ITN's RAVE clinical trial, published August 1st in the New England Journal of Medicine, the ITN is providing unfettered access to the underlying clinical data and analysis code via the new clinical trials research portal, ITN TrialShare. TrialShare is a significant advance in data sharing and transparency, allowing for collaborative hypothesis generation and specimen sharing between the ITN and the broader scientific community. TrialShare gives researchers the ability to access raw study data, confirm published conclusions and interactively perform their own exploratory analyses using this data.

"Direct access to raw clinical trial data will change the landscape of collaborative research" said Peter C. Grayson, MD, MSc of Boston University Medical Center, a collaborator with the ITN. "TrialShare creates unfettered opportunities to explore and understand the intricacies of clinical trial data. Better understanding of primary data leads to better downstream applications of that data."

The FDA has announced that it intends to consider making de-identified and masked subject level data widely available to improve the efficiency and effectiveness of medical product development, recognizing that external experts should become actively engaged in the research. ITN TrialShare was created precisely to address this need, enabling researchers to share the results of the clinical trial data in an open and transparent manner, while protecting the privacy and anonymity of study participants by fully de-identifying the data. TrialShare provides tools that allow external researchers to confirm results while providing access to the underlying data, ensuring that nothing is missed or overlooked. TrialShare also provides access to the ITN specimen repository catalog, allowing users external to the trial to request specimens for follow-up experiments based on the data and available samples.

"TrialShare allows researchers from around the world to have direct access to ITN's clinical trial data" said Gerald T. Nepom, MD, PhD, director of the ITN. "This will enhance scientific collaboration and greatly speed the sharing of the results of our studies."

In recognition of the system's approach to analytic transparency, ITN Trial Share was recently awarded "Best Practices Award – Honorable Mention" at the April, 2013 Bio-IT World Conference in Boston. The Bio-IT World's Best Practices Awards "recognize organizations for their outstanding innovations and excellence in the use of technologies that advance biomedical and translational research, and clinical trials."

With the addition to TrialShare of the data from today's publication, ITN TrialShare currently has data associated with six published manuscripts available to the public in the therapeutic areas of transplant, allergy, auto-immunity and diabetes. ITN will make the underlying data from all published studies, regardless of outcome, available through TrialShare. ITN TrialShare uses the open source LabKey server software. TrialShare can be accessed at ITNTrialShare.org.

### About The Immune Tolerance Network

The Immune Tolerance Network (ITN) is a research consortium sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health along with additional support from NIDDK and JDRF. The ITN develops and conducts clinical and mechanistic studies of immune tolerance therapies designed to prevent disease-causing immune responses, without compromising the natural protective properties of the immune system. Visit http://www.immunetolerance.org for more information.

Contact: Philip Bernstein, PhD
(240) 235 6132
ITNCommunications@immunetolerance.org
Immune Tolerance Network
Office of the Director
1201 Ninth Avenue
Seattle, WA 98101-2795
206-342-6901


ELSE PRESS RELEASES FROM THIS DATE:

Lunch with company reduces cognitive control, may increase social harmony

2013-08-01
Lunch at a restaurant with friends reduces cognitive control more than lunch eaten alone at a desk does, according to research published July 31 in the open access journal PLOS ONE by Werner Sommer from the Humboldt University at Berlin, Germany, and colleagues from other institutions. Participants in the study either ate a solitary meal alone at their desk in a restricted amount of time, or took a short walk to a restaurant for an hour-long lunch with a friend. All meals were identical in the kind and amounts of food consumed. After the meal, people who had a restaurant ...

Placebo effects of different therapies not identical

2013-08-01
Not all placebos are equal, and patients who respond to one placebo don't always respond to others, according to research published July 31 in the open access journal PLOS ONE by Jian Kong from Massachusetts General Hospital, Harvard Medical School and colleagues from other institutions. The researchers tested the analgesic effects of genuine acupuncture, sham acupuncture and a placebo pill on healthy participants' pain sensitivity. Participants were not told what treatment they were receiving, but were informed that the pill was Tylenol, a well-known painkiller and different ...

New signal stabilizes atherosclerotic plaques

2013-08-01
Atherosclerosis is an inflammatory disease with accumulation of cholesterol in the vessel walls. The atherosclerotic plaque is built up throughout life and when it ruptures it leads to heart attack or stroke. T cells are important immune cells able to direct the immune response; they are present in the plaques at all stages and signal to other cells through contact or secretion of cytokines, a type of hormone-like signal molecules. In the present study the researchers have identified a cytokine produced by T cells that can stabilize atherosclerotic plaques and protect them ...

Digest this: Cure for cancer may live in our intestines

2013-08-01
ANN ARBOR—Treating a cancerous tumor is like watering a houseplant with a fire hose—too much water kills the plant, just as too much chemotherapy and radiation kills the patient before it kills the tumor. However, if the gastrointestinal tract remains healthy and functioning, the chances of survival increase exponentially, said Jian-Guo Geng, associate professor at the University of Michigan School of Dentistry. Recently, Geng's lab discovered a biological mechanism that preserves the gastrointestinal tracts in mice who were delivered lethal doses of chemotherapy. ...

Bird brains predate birds themselves

2013-08-01
VIDEO: This video shows the three-dimensional scan of an albatross (Phoebastria immutabilis) skull and brain endocast (shown in blue) taken with high-resolution X-ray computed tomography. The specimen is one of more... Click here for more information. New research provides evidence that dinosaurs evolved the brainpower necessary for flight well before they actually took to the air as birds. Based on high-resolution X-ray computed tomographic (CT) scans, the study, published ...

'Highway from hell' fueled Costa Rican volcano

2013-08-01
If some volcanoes operate on geologic timescales, Costa Rica's Irazú had something of a short fuse. In a new study in the journal Nature, scientists suggest that the 1960s eruption of Costa Rica's largest stratovolcano was triggered by magma rising from the mantle over a few short months, rather than thousands of years or more, as many scientists have thought. The study is the latest to suggest that deep, hot magma can set off an eruption fairly quickly, potentially providing an extra tool for detecting an oncoming volcanic disaster. "If we had had seismic instruments ...

Wonders of nature inspire exotic man-made materials

2013-08-01
In this month's edition of Physics World, a group of physicists describe how unique structures in the natural world are inspiring scientists to develop new types of materials with unprecedented properties. From adhesive tape inspired by the toes of geckoes to a potential flaw-resistant coating of aeroplanes inspired by mother of pearl, the attractiveness centres on one concept -- hierarchical design. When materials have a hierarchical design, the overall structure is made up of much smaller levels, or generations, of structures that when put together exhibit extraordinary ...

Internet-based training could help in the fight against antibiotic resistance

2013-08-01
Antibiotic prescribing rates for acute respiratory tract infections could be significantly lowered using internet-based training for clinicians, new research has shown. In a study, led by the University of Southampton and published in The Lancet today (Wednesday 31 July), an internet-based training programme has shown to reduce antibiotics prescribing rates by as much as 62 per cent. Paul Little, Professor of Primary Care Research at the University of Southampton, comments: "The high volume of prescribing antibiotics in primary care is a major driver of antibiotic resistance, ...

Clean water and soap may help improve growth in young children

2013-08-01
Improving water quality and hygiene practices may improve the growth of children, according to a new report. The Cochrane review – authored by the London School of Hygiene & Tropical Medicine and WaterAid – found evidence of small but significant improvements in growth of children under the age of five who have access to clean water and soap. Researchers identified 14 studies conducted in low and middle income countries (Bangladesh, Ethiopia, Nigeria, Chile, Guatemala, Pakistan, Nepal, South Africa, Kenya and Cambodia) that provided data on the effect of water, sanitation ...

Cleveland Clinic study finds lowest risk treatment for severe carotid and coronary disease

2013-08-01
JULY 31, 2013, Cleveland: Of the three most common treatment approaches for patients with severe carotid and coronary artery disease, patients who underwent stenting of the carotid artery followed by open heart surgery had the best outcomes, according to a retrospective study from Cleveland Clinic published online today in the Journal of the American College of Cardiology. The study compared carotid stenting followed by open heart surgery to both staged and combined carotid endarterectomy and open heart surgery. For patients with a severe blockage in the carotid artery ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] ITN achieves scientific manuscript first -- provides open, interactive access to clinical trial data